{"nct_id":"NCT01539291","title":"Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)","status":"TERMINATED","status_verified_date":"2019-08","start_date":"2012-10-03","start_date_type":"ACTUAL","primary_completion_date":"2018-05-21","primary_completion_date_type":"ACTUAL","completion_date":"2018-06-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}